Pulmonary vascular disorders in hereditary hemorrhagic telangiectasia

Pulmonary Vascular Disorders

Volumn , Issue , 2012, Pages 262-275

  Cottina, Vincent ^a,c   Khouatraa, Chahéra ^a,c   Dupuis Girodb, Sophie ^b,c   Cordiera, Jean François ^a,c  

^a UNIVERSITÉ DE LYON   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c Research Network on Rendu Osler Disease   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893615093     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000334383     Document Type: Chapter

References (29)

1. Faughnan ME, Granton JT, Young LH: The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J 2009; 33:1186-1194.
2. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-67.
3. Cottin V, Chinet T, Lavole A, Corre R, Marchand E, Reynaud-Gaubert M, Plauchu H, Cordier JF, Groupe d'etudes et de recherche sur les maladies 'orphelines' pulmonaires (GERM'O'P): Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 2007;86:1-17.
4. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R: International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73-87.
5. Shovlin CL: Hereditary haemorrhagic telangiectasia:Pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203-219.
6. Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B, Goizet C, Roume J, Rabilloud M, Saurin JC, Cottin V, Honnorat J, Coulet F, Giraud S, Calender A, Danesino C, Buscarini E, Plauchu H: Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia:Data from the French-Italian HHT network. Genet Med 2007;9:14-22.
7. Post MC, Letteboer TG, Mager JJ, Plokker TH, Kelder JC, Westermann CJ: A pulmonary rightto- left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005;128:2485-2489.
8. Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, Loyd JE, Newman JH, Phillips JA, 3rd, Soubrier F, Trembath RC, Chung WK:Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S32-S42.
9. Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M: Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 2008;177:1377-1383.
10. Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jais X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O'Callaghan DS, Simonneau G, Soubrier F, Humbert M: Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 2010;181:851-861.
11. Cottin V, Dupuis-Girod S, Lesca G, Cordier JF:Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler disease). Respiration 2007;74:361-378.
12. Wong HH, Chan RP, Klatt R, Faughnan ME: Idiopathic pulmonary arteriovenous malformations:clinical and imaging characteristics. Eur Respir J 2011;38:368-375.
13. Pierucci P, Murphy J, Henderson KJ, Chyun DA, White RI Jr: New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest 2008;133:653-661.
14. Lacombe P, Lagrange C, Beauchet A, El Hajjam M, Chinet T, Pelage JP: Diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: long-term results of embolization according to the extent of lung involvement. Chest 2009;135:1031-1037.
15. Dupuis-Girod S, Giraud S, Decullier E, Lesca G, Cottin V, Faure F, Merrot O, Saurin JC, Cordier JF, Plauchu H: Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases:an underestimated association. Clin Infect Dis 2007;44:841-845.
16. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C: Pulmonary arteriovenous malformations:evaluation with CT of the chest before and after treatment. Radiology 1992;182:809-816.
17. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF: Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004;169:994-1000.
18. Boussel L, Cernicanu A, Geerts L, Gamondes D, Khouatra C, Cottin V, Revel D, Douek P: 4D time-resolved magnetic resonance angiography for noninvasive assessment of pulmonary arteriovenous malformations patency. J Magn Reson Imaging 2010;32:1110-1116.
19. Zukotynski K, Chan RP, Chow CM, Cohen JH, Faughnan ME: Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT. Chest 2007;132:18-23.
20. Lee WL, Graham AF, Pugash RA, Hutchison SJ, Grande P, Hyland RH, Faughnan ME: Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations. Chest 2003;123:351-358.
21. Trerotola SO, Pyeritz RE: PAVM embolization:an update. AJR Am J Roentgenol 2010;195:837-845.
22. Cottin V, Gamondes D, Schuller A, Coudurier M, Dupuis-Girod S, Tronc F, Cordier JF: Near-fatal haemorrhage from pulmonary arteriovenous malformation in HHT with increased cardiac output. Eur Respir Rev 2009;18:190-192.
23. Buscarini E, Plauchu H, Garcia Tsao G, White RI Jr, Sabba C, Miller F, Saurin JC, Pelage JP, Lesca G, Marion MJ, Perna A, Faughnan ME: Liver involvement in hereditary hemorrhagic telangiectasia:consensus recommendations. Liver Int 2006;26:1040-1046.
24. Dupuis-Girod S, Chesnais AL, Ginon I, Dumortier J, Saurin JC, Finet G, Decullier E, Marion D, Plauchu H, Boillot O: Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Liver Transpl 2010;16:340-347.
25. Flieger D, Hainke S, Fischbach W: Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann Hematol 2006;85:631-632.
26. Mitchell A, Adams LA, MacQuillan G, Tibballs J, van den Driesen R, Delriviere L: Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 2008;14:210-213.
27. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L: Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-334.
28. Shovlin CL, Tighe HC, Davies RJ, Gibbs JS, Jackson JE: Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Respir J 2008;32:162-169.
29. Montani D, Price LC, Girerd B, Chinet T, Lacombe P, Simonneau G, Humbert M: Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH. Eur Respir Rev 2009;18:42-46.